# SAPT Versus DAPT in Incomplete Revascularization After CABG

> **NCT03789916** · PHASE3 · RECRUITING · sponsor: **Campus Bio-Medico University** · enrollment: 800 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Ticagrelor
- **DRUG:** acetylsalicylic acid

## Key facts

- **NCT ID:** NCT03789916
- **Lead sponsor:** Campus Bio-Medico University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-01-02
- **Primary completion:** 2021-08-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2022-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03789916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03789916, "SAPT Versus DAPT in Incomplete Revascularization After CABG". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03789916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*